ROME (ITALPRESS) – “The Plasma Journey,” a photographic exhibition that offers a visual journey through the process of producing life-saving plasma-derived drugs from blood donation, is coming to Rome. The initiative, which has already been hosted in Siena and Florence, is promoted by the Pla.Net consortium (Plasma Network, an interregional agreement that unites Tuscany, Campania, Lazio, Marche and Molise) with the nonconditional support of Takeda. “The goal is to involve the population of young university students in the Lazio region in this initiative that not only offers an informative experience of great impact, but also promotes the culture of solidarity by representing an opportunity to raise awareness of plasma donation,” began Nathan Levialdi Ghiron, rector of the University of Tor Vergata, opening the conference presenting the exhibition, set up from Feb. 5 to 12 in the Gallery area of the Polyclinic.”The title of the exhibition is suggestive because it makes the sense of what happens: it all starts with donation, then from the plasma, plasma-derived drugs are made. The final product is a real drug, and some of them are life-saving. A key aspect is the training and information of donors,” Stefania Vaglio, head of the Lazio Regional Blood Center, instead, explained.Also present was Francesco Buccisano, director of the U.O.S.D. Transfusion Medicine at Policlinico Tor Vergata, who pointed out that the problem is managing the “need for life-saving drugs. There is network work at the regional level, with the Regional Blood Center, but we also need to look inward: we have a huge catchment area represented by young people. It is important to sow the culture of donation and make it germinate, because it is an altruistic act. From a technical point of view, we need to implement collection. We hope to arrive at an adjustment or at least a normalization of the workload. “Takeda is a multinational company that has been a partner of the National Health Service since 2018 and is in charge of transforming plasma into life-saving pharmacies,” said Francesca Micheli, managing director of Takeda Manufacturing Italia. “We are happy to have contributed to the organization of the exhibition, which tells the journey of plasma and promotes donation and pays tribute to the many protagonists of this journey. Europe is suffering, because the amount of plasma is not enough and it has to be brought in from abroad. These are ‘critical’ drugs, because they are not one of the options, but the only treatment alternative.”
– photo spf/Italpress -(ITALPRESS).
